Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Phase 2 Completed
40 enrolled 20 charts
Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence
Phase 2 Completed
26 enrolled 6 charts
Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer
Phase 2 Completed
106 enrolled 12 charts
Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer
Phase 2 Completed
41 enrolled 9 charts
Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer
Phase 2 Completed
121 enrolled 25 charts
MesoPDT
Phase 2 Completed
6 enrolled
CheckMate 6DW
Phase 2 Completed
102 enrolled
LyMa101
Phase 2 Completed
86 enrolled
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Phase 2 Completed
34 enrolled 12 charts
Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma
Phase 2 Completed
60 enrolled
Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
20 enrolled 20 charts
CETUXICOL
Phase 2 Completed
76 enrolled
PINBALL
Phase 2 Completed
27 enrolled
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma
Phase 2 Completed
76 enrolled 10 charts
A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC
Phase 2 Completed
65 enrolled
AACER
Phase 2 Completed
53 enrolled
Cisplatin vs Paclitaxel for Triple Negative Breast Cancer
Phase 2 Completed
147 enrolled 15 charts
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
Phase 2 Completed
17 enrolled 12 charts
Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer
Phase 2 Completed
272 enrolled 17 charts
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Phase 2 Completed
74 enrolled
TPFmORL
Phase 2 Completed
105 enrolled
PPIO-004-EC001
Phase 2 Completed
118 enrolled
KEYVIBE-005
Phase 2 Completed
613 enrolled
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Phase 2 Completed
57 enrolled
ECHO-07
Phase 2 Completed
42 enrolled 24 charts
INNOVATION
Phase 2 Completed
172 enrolled
Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC
Phase 2 Completed
81 enrolled
ECWHCCFLACC
Phase 2 Completed
120 enrolled
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Phase 2 Completed
52 enrolled
KEYNOTE-B99
Phase 2 Completed
126 enrolled
PLATINUM
Phase 2 Completed
152 enrolled
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma
Phase 2 Completed
9 enrolled
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer
Phase 2 Completed
160 enrolled 12 charts
SCARCE
Phase 2 Completed
97 enrolled
Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery
Phase 2 Completed
21 enrolled 18 charts
Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients
Phase 2 Completed
50 enrolled
ATEZOLACC
Phase 2 Completed
189 enrolled
Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
Phase 2 Completed
45 enrolled 17 charts
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
Phase 2 Completed
35 enrolled
neoCHANCE-2
Phase 2 Completed
40 enrolled
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Phase 2 Completed
344 enrolled
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages
Phase 2 Completed
3 enrolled 4 charts
DEPEND
Phase 2 Completed
35 enrolled 14 charts
OPTIMA-II
Phase 2 Completed
72 enrolled 14 charts
Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
Phase 2 Completed
118 enrolled 23 charts
KEYNOTE-799
Phase 2 Completed
216 enrolled 15 charts
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Phase 2 Completed
139 enrolled 14 charts
A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma
Phase 2 Completed
28 enrolled
Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer
Phase 2 Completed
101 enrolled 19 charts
IMMUNEBOOST
Phase 2 Completed
62 enrolled